Abstract
The primary cause of metabolic syndrome is obesity, a state in which the body accumulates stockpiles of fat. Lessening of assimilation of dietary fats via suppression of lipase enzyme of the pancreas may incite weight loss. In this work, 21 isolates of lactic acid bacteria (LAB) were monitored for potential novel probiotic traits by means of in vitro methods, comprising of bile salt and acid tolerance, adhesion and lipase inhibitory activity. The findings illustrated that L. fermentum sp D9, L. fermentum sp S14 and L. fermentum sp S8, L. paracasei S11 and L. brevis S15 demonstrated prominent potential probiotic features as well as lipase inhibitory activity in vitro. The traits of opted isolates were as good as to those of L. rhamnosus PTCC 1637, a similar strain to L. rhamnosus GG, which possessed an antidiabetic aptitude. These findings offered that the abovementioned isolates could be administrated as potent anti-obesity probiotics. It should be noted that, more investigations are necessary to evaluate the inhibitory activity of lipase from these strains.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of microbiology, biotechnology and food sciences
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
